Spire Healthcare Group (LON:SPI) Reaches New 12-Month Low – Here’s Why

Spire Healthcare Group plc (LON:SPI)’s share price hit a new 52-week low on Monday . The company traded as low as GBX 140.80 and last traded at GBX 143, with a volume of 857735 shares traded. The stock had previously closed at GBX 142.80.

Spire Healthcare Group Stock Performance

The stock has a market capitalization of £577.80 million, a P/E ratio of 31.22, a price-to-earnings-growth ratio of 1.06 and a beta of 0.71. The company has a current ratio of 0.63, a quick ratio of 0.74 and a debt-to-equity ratio of 177.14. The company has a 50-day moving average price of GBX 190.35 and a two-hundred day moving average price of GBX 203.24.

Spire Healthcare Group (LON:SPI) last announced its earnings results on Friday, March 6th. The company reported GBX 9.60 EPS for the quarter. Spire Healthcare Group had a return on equity of 2.22% and a net margin of 1.04%. On average, equities analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.